MedTrace Logo

The Asthma Control Rate Achieved by Budesonide/Formoterol in Clinical Practice in China

NCT01785901 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1502

Last updated 2016-08-19

No results posted yet for this study

Summary

This is a multi-centre, cross-sectional study planned to be conducted in China. The study aims to observe about 1500 asthma patients who have already received budesonide/formoterol combination treatment by physicians' determination and whose medications are aligned with the package insert of budesonide/formoterol approved in China.

Conditions

Interventions

OTHER

without interventions

without interventions

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01785901 on ClinicalTrials.gov